Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells
Rui Sun(Tianjin Medical University Eye Hospital), Weili Zhao(Shanghai Jiao Tong University)
Cited by 53
Related Papers
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells
|Molecular Cancer|2019|134
Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression
|Laboratory Investigation|2004|103
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
|Frontiers in Oncology|2020|82